Abstract

We describe, for the first time the use of hydrogel-forming microneedle (MN) arrays for minimally-invasive extraction and quantification of drug substances and glucose from skin in vitro and in vivo. MN prepared from aqueous blends of hydrolysed poly(methyl-vinylether-co-maleic anhydride) (11.1% w/w) and poly(ethyleneglycol) 10,000 daltons (5.6% w/w) and crosslinked by esterification swelled upon skin insertion by uptake of fluid. Post-removal, theophylline and caffeine were extracted from MN and determined using HPLC, with glucose quantified using a proprietary kit. In vitro studies using excised neonatal porcine skin bathed on the underside by physiologically-relevant analyte concentrations showed rapid (5 min) analyte uptake. For example, mean concentrations of 0.16 μg/mL and 0.85 μg/mL, respectively, were detected for the lowest (5 μg/mL) and highest (35 μg/mL) Franz cell concentrations of theophylline after 5 min insertion. A mean concentration of 0.10 μg/mL was obtained by extraction of MN inserted for 5 min into skin bathed with 5 μg/mL caffeine, while the mean concentration obtained by extraction of MN inserted into skin bathed with 15 μg/mL caffeine was 0.33 μg/mL. The mean detected glucose concentration after 5 min insertion into skin bathed with 4 mmol/L was 19.46 nmol/L. The highest theophylline concentration detected following extraction from a hydrogel-forming MN inserted for 1 h into the skin of a rat dosed orally with 10 mg/kg was of 0.363 μg/mL, whilst a maximum concentration of 0.063 μg/mL was detected following extraction from a MN inserted for 1 h into the skin of a rat dosed with 5 mg/kg theophylline. In human volunteers, the highest mean concentration of caffeine detected using MN was 91.31 μg/mL over the period from 1 to 2 h post-consumption of 100 mg Proplus® tablets. The highest mean blood glucose level was 7.89 nmol/L detected 1 h following ingestion of 75 g of glucose, while the highest mean glucose concentration extracted from MN was 4.29 nmol/L, detected after 3 hours skin insertion in human volunteers. Whilst not directly correlated, concentrations extracted from MN were clearly indicative of trends in blood in both rats and human volunteers. This work strongly illustrates the potential of hydrogel-forming MN in minimally-invasive patient monitoring and diagnosis. Further studies are now ongoing to reduce clinical insertion times and develop mathematical algorithms enabling determination of blood levels directly from MN measurements.

Highlights

  • Therapeutic drug monitoring (TDM) aims to promote optimum clinical treatment by maintaining drug levels within a defined therapeutic range [1]

  • This ability of hydrogel-forming MN, as a minimally-invasive mechanism of TDM, is an exciting prospect, as it could negate the use of hypodermic needles, eliminating the pain, bruising and erythema associated with their use [38,39,40,41]

  • Risk of infection would be virtually eliminated by the use of hydrogel-forming MN, since upon intact removal they have insufficient strength in the swollen state to puncture the skin of another patient, thereby negating the risk of needle-stick injuries [39, 40]

Read more

Summary

Introduction

Therapeutic drug monitoring (TDM) aims to promote optimum clinical treatment by maintaining drug levels within a defined therapeutic range [1]. TDM is limited to drugs with a narrow therapeutic window and is most commonly used to detect and prevent toxicity and sub-therapeutic dosing in vulnerable patient populations, such as the elderly, neonates and those with organ dysfunction [2]. TDM plays a crucial role in maintaining health in many diverse populations. It is regularly performed in all patients who have received any form of organ transplantation, is a mainstay of control in many forms of epilepsy and is personally performed by the majority of diabetic patients on a daily basis. Given the predisposition of neonates to infection, they frequently require potent antimicrobial therapy with drugs such as amikacin, gentamicin and vancomycin, all with narrow therapeutic windows and potential for toxicity. As liver and renal function in the elderly, neonatal and critically unwell populations can be significantly different from that of older infants and adults, the clearance of these potentially-toxic drugs is, a significant issue

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.